Pfizer and BioNTech will test the shot on three groups of people. AP
Pfizer and BioNTech will test the shot on three groups of people. AP
Pfizer and BioNTech begin Omicron vaccine trial
More than 1,400 people be involved in the research to test shots’ safety and tolerability